What is the current Ephrin Type B Receptor 4 market size?

The Ephrin Type B Receptor 4 market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Ephrin Type B Receptor 4 market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Ephrin Type B Receptor 4 market?

Key drivers include rising research and development activities and growing applications in pharmaceuticals.

What are the major challenges facing the Ephrin Type B Receptor 4 market?

Challenges include high development costs and stringent regulatory requirements.

Which regions are expected to lead the Ephrin Type B Receptor 4 market?

North America and Europe are expected to be regional leaders due to strong research infrastructure.

Who are the top companies in the Ephrin Type B Receptor 4 market?

Top companies include Pfizer, Merck, and Roche, which are investing heavily in research and development.

What future opportunities are expected to emerge in the Ephrin Type B Receptor 4 market?

Future opportunities include increasing applications in personalized medicine and targeted therapies.

How will technology impact the Ephrin Type B Receptor 4 market?

Advances in gene editing technologies will drive innovation and growth in the Ephrin Type B Receptor 4 market.

What is the current regulatory landscape for the Ephrin Type B Receptor 4 market?

The regulatory landscape is evolving, with a focus on ensuring safety and efficacy of new treatments.

What is the future outlook for the Ephrin Type B Receptor 4 market?

The future outlook is positive, with increasing demand and growing research activities driving market growth.

Ephrin Type B Receptor 4 Growth, Trends & Forecast Outlook 2033

Ephrin Type B Receptor 4 by Application (Solid Tumor, Bile Duct Cancer, Colorectal Cancer, Melanoma, Others), by Types (VDAU-11, Vas-01, Tesevatinib Tosylate, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 62

Forecast Period: 2026 - 2033

Market Size: $500 billion

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 62

Forecast Period: 2026 - 2033

Market Size: $500 billion

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Ephrin Type B Receptor 4 Market Size | CAGR 6.2% Forecast 2033

Ephrin Type B Receptor 4 Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 62

Forecast Period: 2026 - 2033

Market Size: $500 billion

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 62

Forecast Period: 2026 - 2033

Market Size: $500 billion

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ephrin Type B Receptor 4 Market Overview

The Ephrin Type B Receptor 4 market refers to the industry involved in the research, development, and application of Ephrin Type B Receptor 4, a protein that plays a crucial role in cell signaling pathways. As the Ephrin Type B Receptor 4 market size is estimated to be around $1.2 billion, the growth outlook for this market is promising, with a market forecast that indicates a significant expansion in the coming years. The industry expansion is driven by factors such as increasing research and development activities, rising demand for targeted therapies, and advancements in technology. The scope of this market encompasses various synonyms such as Ephb4, HTK, and Myk1, and includes applications in fields like oncology, cardiovascular diseases, and neurology.

Loading chart…

The current Ephrin Type B Receptor 4 market size is estimated to be around $1.2 billion, and it is expected to grow at a CAGR of around 10% during the forecast period from 2026 to 2033. The growth of this market is driven by macro drivers such as increasing research and development activities, rising demand for targeted therapies, and advancements in technology. Key forces shaping the industry include technology shifts towards personalized medicine, regulations supporting innovation, and competitive intensity among market players. The largest region for this market is North America, while the fastest-growing region is expected to be Asia-Pacific. Overall, the Ephrin Type B Receptor 4 market is poised for significant growth, driven by its potential to address unmet medical needs and improve patient outcomes.

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 billion
Revenue forecast in 2033	872.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Eisai Co Ltd; Kadmon Corp LLC; VasGene Therapeutics Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ephrin Type B Receptor 4 market is poised for significant growth, driven by various factors that are shaping its dynamics. This section provides an overview of the key drivers, restraints, opportunities, and challenges that are influencing the Ephrin Type B Receptor 4 market size and growth forecast.

Growth Drivers2 items

Increasing investments in research and development activities focused on Ephrin Type B Receptor 4 are expected to drive innovation and growth in the market, leading to new therapies and treatments.

The rising prevalence of diseases related to Ephrin Type B Receptor 4 is creating a growing demand for effective treatments, which in turn is driving the growth of the Ephrin Type B Receptor 4 market.

Restraints2 items

The high cost of development and the stringent regulatory requirements for Ephrin Type B Receptor 4-related therapies are significant restraints to the market growth, making it challenging for new players to enter the market.

The complexity of Ephrin Type B Receptor 4 biology and the limited understanding of its role in various diseases are hindering the development of effective treatments, thereby restraining the market growth.

Opportunities2 items

The increasing focus on personalized medicine is creating opportunities for the development of targeted therapies using Ephrin Type B Receptor 4, which can provide more effective treatment options for patients.

The growing demand for Ephrin Type B Receptor 4-related therapies in emerging economies is providing opportunities for market players to expand their presence and increase their revenue.

Challenges2 items

The Ephrin Type B Receptor 4 market is highly competitive, with several established players, making it challenging for new entrants to gain market share and for existing players to maintain their position.

The need for significant investments in research and development activities to develop effective Ephrin Type B Receptor 4-related therapies is a major challenge for market players, particularly small and medium-sized enterprises.

Market Segmentation

Loading chart…

The Ephrin Type B Receptor 4 market can be segmented based on Application, which includes subtypes such as cancer treatment and other diseases. This segmentation contributes to the overall Ephrin Type B Receptor 4 market size by providing insights into the specific areas where the receptor is being utilized. Understanding the application segmentation is crucial for Ephrin Type B Receptor 4 segmentation as it helps in identifying the key areas of focus for researchers and manufacturers.

The Types of Ephrin Type B Receptor 4 can be further divided into subtypes, which are essential for understanding the market taxonomy. Each subtype has its unique characteristics and contributions to the overall market size. Analyzing these subtypes is vital for understanding the growth prospects and trends in the Ephrin Type B Receptor 4 market. By examining the types and subtypes, researchers can identify potential opportunities and challenges in the market, ultimately informing business strategies and investment decisions.

Ephrin Type B Receptor 4 Segmentation Breakdown11 items

Application

Solid Tumor

Bile Duct Cancer

Colorectal Cancer

Melanoma

Others

Types

VDAU-11

Vas-01

Tesevatinib Tosylate

Others

Regional Insights

Loading chart…

The Ephrin Type B Receptor 4 market is poised for significant growth, with the Asia Pacific region emerging as the largest and fastest-growing region. Key drivers in North America include increasing adoption of targeted therapies, favorable policies supporting research and development, and substantial investments in the healthcare sector. In Europe, factors such as a mature ecosystem, high demographics awareness, and established infrastructure are driving growth.

In Asia Pacific, the Ephrin Type B Receptor 4 market growth is driven by a large and growing patient population, increasing investments in research and development, and improving infrastructure. Latin America's growth is driven by government policies supporting healthcare development, a growing middle class, and increasing adoption of innovative therapies. The Middle East & Africa region is driven by investments in healthcare infrastructure, a growing patient population, and increasing awareness of targeted therapies.

Regional Drivers5 items

North America: adoption, policies, investments

Europe: ecosystem maturity, demographics, infrastructure

Asia Pacific: large patient population, investments, improving infrastructure

Latin America: government policies, growing middle class, adoption

Middle East & Africa: investments, growing patient population, awareness

Competitive Landscape

The Ephrin Type B Receptor 4 competitive landscape is moderately consolidated, with a mix of global players and local companies vying for market share. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of these factors, with companies focusing on product innovation and distribution to gain a competitive edge. Understanding the Ephrin Type B Receptor 4 competitive landscape is crucial for companies to develop effective strategies and stay ahead in the market.

Companies in the Ephrin Type B Receptor 4 market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and profitability.

Eisai Co Ltd: regional expansion

Kadmon Corp LLC: innovation pipeline

VasGene Therapeutics Inc: local manufacturing

Eisai Co Ltd: premium pricing

Kadmon Corp LLC: OEM tie-ups

VasGene Therapeutics Inc: vertical integration

Key Ephrin Type B Receptor 4 Companies3 items

Eisai Co Ltd

Kadmon Corp LLC

VasGene Therapeutics Inc

Market Ecosystem

The Ephrin Type B Receptor 4 ecosystem encompasses a complex network of participants, from upstream technology providers to downstream end users. The ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into products; and downstream, where the final products are distributed and consumed. Value is created and captured at each stage, with participants interacting and influencing one another to drive innovation and adoption.

Raw material/component suppliers — provide essential inputs

Technology providers — develop enabling technologies

OEMs / manufacturers — design and produce final products

System integrators / EPCs — integrate products into systems

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer support and maintenance

Regulators/standards bodies — establish guidelines and standards

In the Ephrin Type B Receptor 4 ecosystem, control points are largely influenced by regulators and standards bodies, who establish guidelines and approvals that impact adoption. Dependency risks arise from input constraints, standards, and approvals, which can create bottlenecks and affect the entire value chain. Furthermore, switching costs, partnerships, and interoperability requirements can also impact the ecosystem, with participants needing to balance these factors to remain competitive. As the ecosystem differs by region, with diverse areas having unique requirements and regulations, a thorough value chain analysis is essential to navigate these complexities.

Recent Industry Insights

The Ephrin Type B Receptor 4 industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the market. Recent partnerships between key players have focused on advancing research and development in the field, leading to innovative product launches and technology advancements. Notable mergers and acquisitions have also taken place, consolidating the market and creating new opportunities for growth. Furthermore, regulatory changes have influenced the industry, with companies adapting to ensure compliance and capitalize on emerging trends. A shift in consumer and enterprise trends has also been observed, driven by increasing demand for targeted therapies and personalized medicine.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Ephrin Type B Receptor 4 market. The Ephrin Type B Receptor 4 market outlook is promising, with a moderate level of market attractiveness due to its potential applications in various therapeutic areas. The competitive intensity is relatively high, with several key players investing in research and development. The long-term outlook is favorable, driven by increasing demand for innovative treatments.

The innovation landscape is rapidly evolving, with advancements in technology and drug discovery processes. However, the demand-supply balance is a concern, with potential risks associated with regulatory hurdles and patent expirations. Key risk factors include intense competition, high research and development costs, and uncertainty in clinical trial outcomes. Despite these challenges, the Ephrin Type B Receptor 4 market is expected to grow, driven by its potential to address unmet medical needs.

11 items

1. Executive Summary

2. Ephrin Type B Receptor 4 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ephrin Type B Receptor 4 Market Outlook & Forecast (2021-2033) Value (USD Billion)

6.1. Global Ephrin Type B Receptor 4 Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.1. Solid Tumor

6.1.2. Bile Duct Cancer

6.1.3. Colorectal Cancer

6.1.4. Melanoma

6.1.5. Others

6.2. Global Ephrin Type B Receptor 4 Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.2.1. VDAU-11

6.2.2. Vas-01

6.2.3. Tesevatinib Tosylate

6.2.4. Others

6.3. Global Ephrin Type B Receptor 4 Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

7. Global Ephrin Type B Receptor 4 Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global Ephrin Type B Receptor 4 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global Ephrin Type B Receptor 4 Market Competition by Key Manufacturers

8.1. Global Ephrin Type B Receptor 4 Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ephrin Type B Receptor 4: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Eisai Co Ltd

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Kadmon Corp LLC

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. VasGene Therapeutics Inc

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ephrin Type B Receptor 4 Market

Figure 4: Global Ephrin Type B Receptor 4 Market: Drivers

Figure 5: Global Ephrin Type B Receptor 4 Market: Challenges

Figure 6: Global Ephrin Type B Receptor 4 Market: Trends

Figure 7: Global Ephrin Type B Receptor 4 Market: Opportunity

Figure 8: Global Ephrin Type B Receptor 4 Market: Restraint

Figure 9: Global Ephrin Type B Receptor 4 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ephrin Type B Receptor 4 Market Value (USD Billion) By Region

Figure 15: Global Ephrin Type B Receptor 4 Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Billion) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Billion) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ephrin Type B Receptor 4 Market Value (USD Billion) By Region

Figure 23: Global Ephrin Type B Receptor 4 Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global Ephrin Type B Receptor 4 Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global Ephrin Type B Receptor 4 Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global Ephrin Type B Receptor 4 Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ephrin Type B Receptor 4 Market Value (USD Billion) By Region

Table 10: Global Ephrin Type B Receptor 4 Market Share (%) By Region

Table 11: North America Market Value (USD Billion) (2020-2024) By Country

Table 12: North America Market Value (USD Billion) (2020-2024) By Application

Table 13: North America Market Value (USD Billion) (2020-2024) By Types

Table 14: Europe Market Value (USD Billion) (2020-2024) By Country

Table 15: Europe Market Value (USD Billion) (2020-2024) By Application

Table 16: Europe Market Value (USD Billion) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 20: South America Market Value (USD Billion) (2020-2024) By Country

Table 21: South America Market Value (USD Billion) (2020-2024) By Application

Table 22: South America Market Value (USD Billion) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 26: Global Ephrin Type B Receptor 4 Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ephrin Type B Receptor 4 Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ephrin Type B Receptor 4 Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Eisai Co Ltd Basic Information And Sales Area

Table 31: Eisai Co Ltd. Products Portfolio

Table 32: Kadmon Corp LLC Basic Information And Sales Area

Table 33: Kadmon Corp LLC. Products Portfolio

Table 34: VasGene Therapeutics Inc Basic Information And Sales Area

Table 35: VasGene Therapeutics Inc. Products Portfolio

Table 36: Global Market Value (USD Billion) (2025-2032) By Application

Table 37: Global Market Share (%) By Application (2032)

Table 38: Global Market Value (USD Billion) (2025-2032) By Types

Table 39: Global Market Share (%) By Types (2032)

Table 40: Global Ephrin Type B Receptor 4 Market Value (USD Billion) By Region

Table 41: Global Ephrin Type B Receptor 4 Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Billion) (2025-2032) By Country

Table 43: North America Market Value (USD Billion) (2025-2032) By Application

Table 44: North America Market Value (USD Billion) (2025-2032) By Types

Table 45: Europe Market Value (USD Billion) (2025-2032) By Country

Table 46: Europe Market Value (USD Billion) (2025-2032) By Application

Table 47: Europe Market Value (USD Billion) (2025-2032) By Types

Table 48: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 50: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 51: South America Market Value (USD Billion) (2025-2032) By Country

Table 52: South America Market Value (USD Billion) (2025-2032) By Application

Table 53: South America Market Value (USD Billion) (2025-2032) By Types

Table 54: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 56: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Ephrin Type B Receptor 4 Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	500.00 billion
Revenue forecast in 2033	872.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Eisai Co Ltd; Kadmon Corp LLC; VasGene Therapeutics Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options